Farmak expands its range of drugs for treatment of acute (stroke) and chronic cerebrovascular disorders – Lira (citicoline). The Company's experts have developed and launched Lira as 30 ml syrup.
Farmak is actively working towards the treatment of cardiovascular and cerebrovascular diseases. In particular, it focuses on ensuring full-scale provision of proper quality and affordable treatment of acute and chronic cerebral circulation disorders in adults, and neurological diseases in children. To that end, the Company's experts have developed and launched the medicinal product Lira as 30 ml syrup.
The medicinal product is prescribed to adult patients in the acuity period and on the following states:
Lira Syrup can also be used to treat muscle hypertonia of the lower extremities in children, encephalopathy, infantile cerebral paralysis (ICP), traumatic brain injury, effects of neuroinfections, and ischemic conditions during prenatal development.
The course of treatment is at least 45 days.
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...
Компанія зайняла перше місце серед найбільших компаній у рейтингу «Виробництво ліків» Також ПАТ «Фармак» увійшов до рейтингів: «Рейтинг найбільших експортерів», «Рейтинг найбільших платників податків», «Рейтинг компаній по об’єму виручки». ПАТ «Фармак» – національний виробник лікарських засобів європейського ринку. Завдяки високій якості продукції та ...